2011 - ISBTS 2011 Symposium

Oral Communications 4: Intestinal Immunosuppression / Rejection

6.134 - Comparison between oral and intravenous induction with tacrolimus in intestinal transplantation patients

Presenter: Khalid, Sharif, Birmingham, United Kingdom
Authors: Ahmed Taha1, Girish Gupte1, Basem Khalil1, Darius Mirza1, Khalid Sharif1

Comparison between oral and intravenous induction with tacrolimus in intestinal transplantation patients

Ahmed Taha, Girish Gupte, Basem Khalil, Darius Mirza, Khalid Sharif

Liver Unit (including small bowel transplantation), Birmingham Children Hospital, Birmingham, United Kingdom

Background/Aim: Achieving optimal tacrolimus level (TL), either by oral (O-T) or IV route (IV-T), early post intestinal transplantation (ITx) is ideal. Aim is to report on a single centre experience with IV-T.

Patients and Methods: Records of two groups were retrieved from a prospectively maintained database. Group-1 was started on O-T dose of 0.075 mg/kg/dose, this was changed to IV-T 24-hour-infusion of 0.15 mg/kg/day if low levels persist. Group-2 was started on IV-T 24-hour-infusion of 0.05 mg/kg/day. Target TL’s (measured once daily) for both groups were aimed at 15-20 ng/ml in the 1st 3 weeks then 12-15 ng/ml till third month. Values are 1st-30-days medians (range).



Group-1 (n=10)

Group-2 (n=11)

Age, months

24 (12-54)

40 (15.7-169.4)

Gender (male/female)



Days of IV-T

18 (1-26)

16.3 (4-30)

Median TL of each patient’s 1st-30-days-mean

18.1 ng/ml

18.5 ng/ml

Rejection episodes while on IV-T

3 (mild to moderate)

2 (severe)

Post-transplant lympho-proliferative disease (PTLD) episodes (1st 6 months)



TL’s were higher than target range 47% of days while on IV-T and were lower than target 42% of days while on O-T, despite frequent dose modification (3times/5days for IV-T and every other day for O-T) and 4 rejections episodes occurred while TL’s were within target. 9/10 patients in Group-1 were switched to IV-T on the 5th day (3-29). Group-2 patients were converted from IV-T to O-T within 5 days (0-14). Higher incidence of PTLD and opportunistic infections in children receiving IV-T at induction.

Conclusion: IV-T usage should be avoided in post-ITx population as more information is needed about pharmacokinetics and leads to higher incidence of complications (breakthrough episodes of rejection and opportunistic infections).

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi